MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?

被引:48
作者
Jabrane-Ferrat, N
Nekrep, N
Tosi, G
Esserman, L
Peterlin, BM
机构
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA
[3] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, San Francisco, CA 94115 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94115 USA
[5] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94115 USA
[6] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana, Slovenia
[7] Univ Insubria, Dept Clin & Biol Sci, Varese, Italy
关键词
activator; assembly; nuclear factor Y; regulatory factor X; transcription;
D O I
10.1093/intimm/dxg048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC class II (MHCII) determinants play a crucial role in the immune response by presenting antigenic peptides to T cells. Their expression is controlled from compact promoters at the transcriptional level. Pre-assembled regulatory factor X (RFX) and nuclear factor Y (NFY) complexes form a platform on DNA. The class II transactivator (CIITA) can then be recruited through multiple protein-protein interactions. In this report, we defined domains of CIITA that are responsible for its interactions with these DNA-bound factors. Furthermore, using DNA-affinity precipitation, we demonstrated that although CIITA binds at least five activators, RFX5, RFXAP, RFXANK/B, NFYB and NFYC, its assembly on the promoter requires the addition of nuclear extracts. We conclude that not only does the platform bind DNA via multiple, spatially constrained nteractions, but that it can recruit only modified and/or complexed CIITA to MHCII promoters.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 25 条
[11]   Major histocompatibility complex class II transcriptional platform: Assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers [J].
Jabrane-Ferrat, N ;
Nekrep, N ;
Tosi, G ;
Esserman, LJ ;
Peterlin, BM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5616-5625
[12]  
JabraneFerrat N, 1996, MOL CELL BIOL, V16, P4683
[13]   Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection [J].
Kanazawa, S ;
Okamoto, T ;
Peterlin, BM .
IMMUNITY, 2000, 12 (01) :61-70
[14]   Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator [J].
Kretsovali, A ;
Agalioti, T ;
Spilianakis, C ;
Tzortzakaki, E ;
Merika, M ;
Papamatheakis, J .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6777-6783
[15]   Role of the CCAAT-binding protein CBF/NF-Y in transcription [J].
Maity, SN ;
de Crombrugghe, B .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (05) :174-178
[16]   The molecular biology of the CCAAT-binding factor NF-Y [J].
Mantovani, R .
GENE, 1999, 239 (01) :15-27
[17]  
Masternak K, 2000, GENE DEV, V14, P1156
[18]   A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients [J].
Masternak, K ;
Barras, E ;
Zufferey, M ;
Conrad, B ;
Corthals, G ;
Aebersold, R ;
Sanchez, JC ;
Hochstrasser, DF ;
Mach, B ;
Reith, W .
NATURE GENETICS, 1998, 20 (03) :273-277
[19]   Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex [J].
Nekrep, N ;
Jabrane-Ferrat, N ;
Peterlin, BM .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) :4455-4461
[20]   Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome [J].
Nekrep, N ;
Geyer, M ;
Jabrane-Ferrat, N ;
Peterlin, BM .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) :5566-5576